Cc1nn(Cc2ccc(Cl)cc2Cl)c(C)c1NC(=O)C1C2CCC(O2)C1C(=O)O
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?